Single Dose Bronchodilatory Study in Asthma

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Study to evaluate the bronchodilator effects of Zyflo CR in patients with chronic stable asthma.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cornerstone Therapeutics Inc.
• Treatments: Zileuton

Criteria

Inclusion Criteria:

• Diagnosis of asthma for at least 5 years

• FEV1 of 50-85% predicted

• Reversible airway obstruction

Exclusion Criteria:

• Pregnant/nursing females

• Liver function tests greater than upper limit of normal